- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kyntra Bio Inc (KYNB)
Kyntra Bio Inc stock price live, this page displays NASDAQ KYNB stock exchange data. View the KYNB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kyntra Bio Inc real time stock price chart below.
What Is the Kyntra Bio Inc Stock Price Today?
The Kyntra Bio Inc stock price today is 7.130.
What Is the Stock Symbol for Kyntra Bio Inc?
The stock symbol for Kyntra Bio Inc is "KYNB."
What Stock Exchange Does Kyntra Bio Inc Trade On?
Kyntra Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Kyntra Bio Inc a Good Stock to Buy?
Determining whether Kyntra Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KYNB quote. (ISIN: US31572Q8814)
What Is the Kyntra Bio Inc Stock Price Today?
The Kyntra Bio Inc stock price today is 7.130.
What Is the Stock Symbol for Kyntra Bio Inc?
The stock symbol for Kyntra Bio Inc is "KYNB."
What Stock Exchange Does Kyntra Bio Inc Trade On?
Kyntra Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Kyntra Bio Inc a Good Stock to Buy?
Determining whether Kyntra Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KYNB quote. (ISIN: US31572Q8814)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.130
7.442
52 wk Range
4.850
12.600
KYNB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.1307.442
52 wk Range
4.85012.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KYNB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
43.000
Upside
+503.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Kyntra Bio Inc Earnings Call Summary for Q2/2025
- FibroGen reports Q2 2025 EPS of -$1.88, missing forecast of -$0.09; revenue falls short at $1.3M vs $2.88M expected
- Stock drops 3.9% to $8.71 post-earnings; company valued at $34M market cap, deemed overvalued by InvestingPro analysis
- Operating costs decrease 72% YoY; R&D expenses down 82%; company extends cash runway to 2028
- Full-year 2025 revenue guidance set at $6M-$8M; Phase II trial for prostate cancer treatment FG3246 to begin Q3 2025
- CEO expresses optimism about clinical programs; CFO highlights financial strategies to benefit shareholders
Last Updated: 2025-08-11, 05:46 p/m
Read Full TranscriptCompare KYNB to Peers and Sector
Metrics to compare | KYNB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKYNBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | 13.7x | −0.5x | |
PEG Ratio | 0.00 | 0.11 | 0.00 | |
Price/Book | −1.0x | 4.8x | 2.6x | |
Price / LTM Sales | 4.5x | 4.1x | 3.1x | |
Upside (Analyst Target) | - | 204.9% | 57.5% | |
Fair Value Upside | Unlock | 23.7% | 8.6% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 43.000
(+503.09% Upside)
Earnings
Latest Release
Mar 16, 2026
EPS / Forecast
-3.61 / -0.24
Revenue / Forecast
1.28M / 2.2M
People Also Watch
FAQ
What Is the Kyntra Bio (KYNB) Stock Price Today?
The Kyntra Bio stock price today is 7.130 USD.
What Stock Exchange Does Kyntra Bio Trade On?
Kyntra Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Kyntra Bio?
The stock symbol for Kyntra Bio is "KYNB."
What Is the Kyntra Bio Market Cap?
As of today, Kyntra Bio market cap is 28.850M USD.
What Is Kyntra Bio's Earnings Per Share (TTM)?
The Kyntra Bio EPS (TTM) is 45.380.
From a Technical Analysis Perspective, Is KYNB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Kyntra Bio Stock Split?
Kyntra Bio has split 1 times.
How Many Employees Does Kyntra Bio Have?
Kyntra Bio has 225 employees.
What is the current trading status of Kyntra Bio (KYNB)?
As of Mar 22, 2026, Kyntra Bio (KYNB) is trading at a price of 7.130 USD, with a previous close of 7.300 USD. The stock has fluctuated within a day range of 7.130 USD to 7.442 USD, while its 52-week range spans from 4.850 USD to 12.600 USD.
What Is Kyntra Bio (KYNB) Price Target According to Analysts?
The average 12-month price target for Kyntra Bio is 43.000 USD, with a high estimate of 43 USD and a low estimate of 43 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +503.09% Upside potential.
What Is the KYNB After Hours Price?
KYNB's last after hours stock price is 7.132 USD, the stock has decreased by 0.002, or 0.030%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.